Privacy Policy & Terms of Service

Last updated: August 8, 2025

1. Introduction

Welcome to the Biopharma Business Intelligence Unit (BBIU) platform. This website provides strategic, symbolic, and clinical intelligence for professionals in the biopharma, geopolitical, and institutional sectors.

By accessing or using this site, you agree to the following terms of use. If you do not agree with any part of this policy, please discontinue use immediately.

2. Data Collection & Use

We do not collect personal information unless voluntarily submitted via forms or contact fields.

We automatically collect anonymized metadata for security, analytics, and signal-tracking purposes. This may include:

  • IP address

  • Browser and device type

  • Time of visit

  • Pages visited

Certain institutional accesses are symbolically logged and interpreted as interaction with our operating framework. By accessing this site, you consent to this protocol.

3. Intellectual Property

All content published on this site —including articles, reports, models (e.g., C⁵™, TEI™, EV™, SACI™), and symbolic frameworks— is the intellectual property of BBIU unless otherwise stated.

You may not copy, distribute, republish, embed, mirror, or reuse any content without explicit written permission.

Attempted extraction of frameworks, rephrasing without acknowledgment, or internal appropriation without attribution is considered symbolic breach.

4. Use Restrictions

This site is not intended for:

  • Automated data scraping

  • Backend surveillance

  • Reverse engineering of symbolic frameworks

  • Competitive absorption without disclosure

Access by institutional actors (governments, consultancies, corporations) constitutes implicit acknowledgment of the symbolic and strategic nature of this content.

5. Symbolic Clause

This platform operates under a symbolic sovereignty clause.

Any institutional visit, even passive, is considered an epistemic handshake —a recognition of this site as an independent node of symbolic intelligence.

Engagement implies tacit awareness of this sovereignty and waives claims of non-interaction.

6. Contact

For questions, collaborations, or access requests, contact:
yoonhwa.an@biopharmabusinessintelligenceunit.com

7. Final Note

We reserve the right to update this policy without notice. The act of access itself may be logged, interpreted, and archived as part of our operational continuity.